Blend of imaging, treatments allows...
A select number of high-risk pancreatic cancer patients initially deemed inoperable are, in fact, eligible for surgery and have a chance for a cure, thanks to a treatment protocol pioneered at MD Anderson.
The protocol combines a more accurate reading of CT scans, the use of chemo-radiation upfront and an advanced surgical resection of the pancreas and removal and reconstruction of appropriate blood vessels. Jason Fleming, M.D...
Researchers develop tool to predict benefit of radiation therapy
During the next two decades, breast cancer diagnoses in older women are expected to increase by 57%. It's a reality that highlights...
"Grab2" grip on growth factor receptor guides crucial signaling
The protein Grb2, once considered merely a passive link between other proteins, acts as an on-off switch for a critical growth...
Intact tumor suppressor hinders one type...
A gene most commonly known as a tumor-suppressor appears to help breast cancer cells survive treatment by a common chemotherapy drug.
In the June 12 edition of Cancer Cell, MD Anderson researchers report that normal p53 thwarts the effects of doxorubicin while mutated versions of the gene improved the drug's effect. Doxorubicin is an anthracycline, a class of antibiotics used to treat a variety of cancers.
The p53 gene regulates...
New drugs being discussed at the Annual American Society of...
The Annual American Society of Clinical Oncology (ASCO) meeting will be discussing several new drugs in development. We have been...